期刊文献+

慢性丙型病毒性肝炎患者血清sICAM-1与肝组织病理变化的相关性研究 被引量:3

下载PDF
导出
摘要 目的:评价sICAM-1在慢性丙型肝炎诊治中的临床意义。方法:对146例慢性丙型肝炎患者血清sICAM-1和肝活检病理改变等进行相关性研究。结果:血清sICAM-1水平在慢性丙肝中、重度组和肝硬化组较对照组明显升高。结论:血清sICAM-1的检测可作为临床判断慢性丙型肝炎病情严重程度和预后的免疫学指标之一。
出处 《中国当代医药》 2009年第25期124-125,共2页 China Modern Medicine
  • 相关文献

参考文献5

  • 1Moriyama M,Matsumura H,Shioda J,et al.Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis[J].Intervirology,2006,49:327-328.
  • 2Satoh S,Nossler AK,Liu ZZ,et al.Proinflammatory eytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes[J].Immunology,1994,82(4):571 - 576.
  • 3Abdalla A,Sheesha AA,Shokeir M,et al.Serum intercellular adhesion molecule-1 in children with chronic liver disease:relationship to disease activity[J].Dig Dis Sci,2002,47(6):1206-1208.
  • 4Doi T,Yamada G,Mizuno M,et al.Immunohistochemical study of the distribution of intercellular adhesion molecule-1 and lymphocyte functionassociated antigen-1 in chronic type B hepatitis[J].J Gastroenterol,1994,29 (2):164-171.
  • 5Horiike N,Onji M,Kumon I,et al.Intercellular adhesion molecule-1 expression on the hepatocyte membrane of patients with chronic hepatitis B and C[J].Liver,1993,13:10-14.

同被引文献20

  • 1王齐欣,魏来,高燕,孙德贵,蒋栋,徐小元,陈红松,王宇.丙型肝炎病毒感染自然过程中的准种变化[J].中华传染病杂志,2004,22(5):323-326. 被引量:12
  • 2Moriyama M,Matsumura H,Shioda J,et al.Measurement of human intercel-lular adhesion molecule 1 in the blood is useful for predicting the OC-currenee of hepatoeellular carcinomas from chronic hepatitis C and liver cirrhosis.Intervirology,2006,49:327-328.
  • 3Lee SR,Peterson,J,N iven P,et al.Efficacy of a hepatitis Cvirns,co re antigen enzyme linked im muo sirbent assay for the identifica2 tion of 'w indow phas' blood donatisons[J].Jvox Sanguinis,2001,80 (3):19-22.
  • 4BuschMP,Kleinman SH,Jackson B,et al.Nucleic acid amp lificationtesting of blood donors for transfusion-tranmitted infectious diseases[J].Transfusion,2000,40:143-1591.
  • 5Alter HJ,Seeff LB.Recovery persistence and sequelae in hepatitis Cvirus infection:a perspective on long-term outcome[J].Semin LiverDis,2000,20:17-351.
  • 6Liang M,Wang L, Ma CX,et a/.Sandwich immunoassay for hepatitis C virus non-structural 5A protein using a glassy carbon electrode modified with an Au-MoO3/chitosan nanocomposite[J].Anal Lett, 2013,46 ( 8 ) : 1241-1254.
  • 7Martins T, Narciso-Schiavon JL, Schiavon Lde L.Epidemi- ology of hepatitis C virus infeetion[J].Rev Assoc Med Bras, 2011 ,57(1) : 107-112.
  • 8Chevaliez S.Virological tools to diagnose and monitor hep- atitis C virus infection[J].Clin Microbiol Infect,2011,17(2) : 116-121.
  • 9Xing XK,Li SJ,He JL,et a/.Inhibition of hepatitis C virus replication by single and dual small interfering RNA using an I-ICV-infeeted cell model[J].Bioteehnol Lett,2012,34(2) : 295-301.
  • 10Jiang L,Gu Y,Ye J,et a/.Resveratrol prevents hepatic steatosis indueed by hepatitis C virus core protein[J].Bioteeh- nol Lett, 2012,34(12) : 2205-2212.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部